L-2-Imidazolidone-4-carboxylic acid is an effective competitive inhibitor of the reaction catalyzed by 5-oxoprolinase, in which 5-oxo-L-proline (L-pyroglutamic acid, L-2-pyrrolidone-5-carboxylic acid, L-5-oxopyrrolidine-2-carboxylic acid) is converted to L-glutamate, with concomitant cleavage of ATP to ADP and orthophosphate. L-2-Imidazolidone-4-carboxylate decreased the rate of metabolism of 5-oxo-L-['4C]proline to 14CO2 by rat-kidney slices but had no effect on the metabolism of [14C] 5-Oxo-i-proline + ATP + 2 H20 5-oxoprolinase
The need for energy in this reaction is consistent with the 5-oxoproline-glutamate equilibrium, which markedly favors cyclization. This enzyme, which has been found in several animal tissues, has been purified from rat kidney (1, 2). While 5-oxoproline has previously been found at the Nterminus of several proteins, its metabolic role as a free compound has only recently become apparent. formed by the action of -y-glutamylcyclotransferase on 7- glutamylamino acids (3) (4) (5) . The conversion of 5-oxoproline to glutamate catalyzed by 5-oxoprolinase thus links reactions involved in the utilization of glutathione (catalyzed by yglutamyltranspeptidase and 'y-glutamylcyclotransferase) to those that are required for the synthesis of glutathione (catalyzed by y-glutamylcysteine synthetase and glutathione synthetase). It has been suggested that these reactions, functioning in a cyclic manner, mediate the transport of amino acids across the renal tubule (5) .
Earlier work in this laboratory (1, 2, 5) (2) . BALB/c mice (18-22 g) were used. L-and D-2-Imidazolidone4-carboxylic acids were prepared from the corresponding isomers of N-carbobenzoxyasparagine by the Hofmann reaction (8) .
Methods. Enzyme activity was determined in reaction mixtures (final volume, 0.5 ml) containing purified rat-kidney 5-oxo-L-prolinase (2), 2 
RESULTS

Studies on 5-oxoprolinase
When the reaction catalyzed by 5-oxoprolinase was performed in the presence of L-2-imidazolidone4-carboxylate, there was marked inhibition of the conversion of 5-oxoproline to glutamate. Similar studies with D-2-imidazolidone-4-carboxylate revealed no inhibition. As indicated by the data given in Fig.  1 , inhibition by L-2-imidazolidone-4-carboxylate is competitive with respect to 5-oxo-L-proline. The data lead to an apparent Km value of 0.05 mM for 5-oxo-i-proline and a Kf value of 0.11 mM for i,2-imdazolidone-4-carboxylate.
Metabolic studies
The data given in Table 1 boxylate. In similar studies in which the oxidation of [14C]-glutamate was studied in the presence of 10 mM L-2-imidazolidone-4-carboxylate (Exp. 2) , there was no inhibition.
In the experiments described in excreted, mainly as 5-oxoproline, in the urine ill 24 hr. In an experiment on the control, respiratory 14CO2 accounted for 17% of the administered dose in 2.5 hr, and 6% of the radioactivity, mostly in the form of glutamate, was excreted in the urine. Both the patient and the control metabolized ["C]-glutamate efficiently and at about the same rate. The available information indicates that the patient probably has a deficiency of renal 5-oxoprolinase activity.
The present findings seem to offer an approach to an animal model for this disease. The evidence derived from enzymatic studies, metabolic experiments, and the clinical observations support the conclusion that 5-oxoproline is a normal metabolite. Indeed, the data on 5-oxoprolinuria would seem to indicate that the formation and utilization of 5-oxoproline is quantitatively quite large, perhaps of the order of 0.5 mol/ day, in man.
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